Mark James Daniel - 14 Oct 2025 Form 3 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role
Chief Financial Officer
Signature
/s/ Mark James Daniel
Issuer symbol
ATOS
Transactions as of
14 Oct 2025
Transactions value $
$0
Form type
3
Filing time
21 Oct 2025, 16:05:06 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Daniel Mark James Chief Financial Officer C/O ATOSSA THERAPEUTICS, INC., 10202 5TH AVENUE NE SUITE 200, SEATTLE /s/ Mark James Daniel 21 Oct 2025 0002092593

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney